2025-01-01 00:00:00
A prebiotic dietary pilot intervention restores faecal metabolites and may be neuroprotective in Parkinson’s DiseaseCategories
View AllConditions
View AllDefinitions
View AllGuides & Resources
View AllInterventions
View AllMicrobes
View AllMetals
View AllResearch Feeds
View AllKaren Pendergrass, Standards Team
About
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.
Recent Posts
2025-01-01 00:00:00
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study2025-01-01 00:00:00
Cervicovaginal microbiome and natural history of Chlamydia trachomatis in adolescents and young women2025-01-01 00:00:00
Exploring the female genital tract mycobiome in young South African women using metaproteomics2024-12-30 13:16:46
Association between Gut Microbiota and Breast Cancer: Diet as a Potential Modulating FactorThis study links reduced gut microbial diversity and specific taxa (e.g., Acidaminococcus, Hungatella) to breast cancer, influenced by diet. Findings suggest microbiome-targeted interventions and dietary strategies could mitigate breast cancer risk.
2024-12-30 12:33:22
Breast cancer patients from the Midwest region of the United States have reduced levels of short-chain fatty acid-producing gut bacteriaThis study identifies gut dysbiosis in breast cancer patients, highlighting reduced CFA-producing bacteria and altered microbial pathways. Findings suggest microbiome-targeted interventions could aid breast cancer treatment.
2024-12-30 12:20:05
Composition and Functional Potential of the Human Mammary Microbiota Prior to and Following Breast Tumor DiagnosisThis study explores the mammary microbiota’s composition and function before and after breast cancer diagnosis, revealing dysbiosis and metabolic shifts as early markers.
2024-12-30 12:05:54
A comprehensive analysis of breast cancer microbiota and host gene expressionThe study analyzed breast tumor and adjacent tissues, linking microbiota composition to cancer pathways. Key findings implicate specific microbes in breast cancer progression.
2024-12-29 12:34:39
Comprehensive profiles and diagnostic value of menopausal-specific gut microbiota in premenopausal breast cancerWhat was studied?This study investigated the gut microbiota profiles, diagnostic value, and functional pathways specific to premenopausal breast cancer patients. It aimed to identify unique gut microbial markers distinguishing premenopausal breast cancer patients from postmenopausal patients and age-matched controls. The study also explored functional pathways of gut microbiota linked to breast cancer progression and diagnostic […]
2024-12-29 09:39:04
Current Updates on the Role of Microbiome in Endometriosis: A Narrative ReviewThis review highlights microbiome alterations in endometriosis, including gut and vaginal dysbiosis, and explores microbiome-targeted therapies and diagnostics.